HPLC vs LC-MS in Peptide Quality Evaluation

Reversed-phase HPLC separates components according to their interaction with a stationary phase and reports detector response over time. Its area-percent result is commonly used to describe chromatographic purity under the stated conditions.

LC-MS couples separation with mass detection and supplies mass-to-charge evidence for eluting species. It is especially useful for checking whether a peak is consistent with the expected molecular mass, but detection response is not inherently quantitative across compounds.

Review the complete chromatogram, not only the reported purity. The run time, gradient, wavelength, baseline behavior, integration markers, solvent front and late-eluting region can determine whether relevant peaks were included.

Area normalization assumes that detected components respond comparably enough for the intended interpretation. Co-elution, weakly absorbing impurities and compounds outside the acquisition window can cause a clean-looking trace to overstate compositional simplicity.

Peptides commonly appear as several charged ions rather than one molecular-ion peak. The reported neutral mass should be consistent with the charge-state series and with whether the calculation uses average or monoisotopic mass.

Adducts, in-source fragments, oxidation products and deletion sequences can complicate spectra. A matching expected mass supports identity, yet it does not prove sequence order, stereochemistry, site-specific modification or absence of isobaric species.

A useful package links chromatographic and spectral data through sample identifier, acquisition time and retention time. The strongest interpretation shows that the principal chromatographic peak carries mass evidence consistent with the intended peptide.

Method selection should follow project risk and specification needs. Additional tools such as amino acid analysis, peptide mapping, water determination or counterion analysis may be necessary when content or structural detail matters.